◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

BOSTON SCIENTIFIC CORP

CIK: 885725 SIC: 3841 MARLBOROUGH, MA
Loading stock data...
Key Financial Metrics (TTM | FY 2025)
$20.07B
Revenue
$2.89B
Net Income
1.94
EPS (Diluted)
$5.50B
Free Cash Flow
Profitability
Gross Margin 69.02%
Operating Margin 18.00%
Net Profit Margin 14.41%
EBITDA $5.97B
Returns & Efficiency
Return on Assets (ROA) 6.62%
Return on Equity (ROE) 11.93%
Gross Profit $13.86B
Operating Income $3.61B
Financial Health
Total Assets $43.67B
Total Debt $11.44B
Debt to Equity -x
Current Ratio 1.62
Debt Analysis
Debt to EBITDA -
Debt to Free Cash Flow -
Cash & Equivalents -
Net Debt -
Capital Returns
Return on Invested Capital (ROIC) -
Invested Capital -
Stockholders Equity -
Revenue Growth -
Market Valuation
Market Cap -
P/E Ratio -
Price to Book -
EPS (Diluted) $1.94
Quick Access Filings
10-K
Annual Report

Loading...

10-Q
Quarterly Report

Loading...

8-K
Recent News

Loading...

Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral Open Market Buys: - Open Market Sales: - Option Exercise & Sale: - Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral 0 Buys $0 0 Sales $0 0 Exercises $0 Net: $0
Insider Title Date Type Shares Price Value
Company Information
Business Address 300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
Phone 508-683-4000
Incorporated DE, US
EIN 042695240
Fiscal Year End 1231
Stockholders' Equity $24.23B
Cash & Equivalents $1.97B
Recent Filings View All
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
425 Prospectus Communications
Prospectus communications under Securities Act
Filed: 2026-03-03
Local
8-K Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-26
Local
3 Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-02-24
Local
3 Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-02-24
Local
8-K Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-23
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-18
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-18
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-18
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-18
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-18
Local
Financial Statistics
Valuation
Market Cap -
P/E Ratio (TTM) -
Price to Book -
EV/Revenue -
EV/EBITDA -
Profitability
Gross Margin 69.0%
Operating Margin 18.0%
Net Margin 14.4%
ROE 11.9%
ROA 6.6%
Leverage & Liquidity
Debt to Equity -
Current Ratio 1.62
Total Debt $11.44B
Total Assets $43.67B
Stockholders' Equity $24.23B
Income Statement (FY 2025)
Revenue $20.07B
Gross Profit $13.86B
Operating Income $3.61B
Net Income $2.89B
EPS (Diluted) $1.94
Cash Flow (FY 2025)
Free Cash Flow $5.50B
Cash & Equivalents $1.97B
Revenue Growth 0.0%
Loading...

Loading management data...

Loading...

Loading board of directors...

Loading...

Loading institutional holders...

NEWS
Loading news...
TRENDING
Loading...